In­ter­im no more: Ash­ley Ma­g­a­rgee to fill Genen­tech CEO post; Pfiz­er, Mod­er­na make com­mer­cial lead­er­ship ad­just­ments

Ash­ley Ma­g­a­rgee will be­come the CEO of Genen­tech on Jan. 1, two decades in­to her tenure at the South San Fran­cis­co biotech pi­o­neer, which she joined pri­or to its $47 bil­lion deal with now-par­ent Roche.

She’s held the in­ter­im post since Nov. 1, when Alexan­der Hardy left in a sur­prise move to take the same post at Bio­Marin. Ma­g­a­rgee will re­port to the CEO of Roche Phar­ma, Tere­sa Gra­ham, who her­self worked up the cor­po­rate lad­der of Genen­tech and Roche on a sim­i­lar timetable and be­came the leader of its phar­ma busi­ness in March 2023.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.